The bill makes it a deceptive trade practice under the Colorado
Consumer Protection Act for a manufacturer to fail to comply with:
•
The insulin affordability program; and
•
The requirements for the emergency supply of prescription insulin.
The bill authorizes the attorney general to enforce: •
The insulin affordability program;
•
The requirements for the emergency supply of prescription insulin; and
•
The epinephrine auto-injector affordability program (epinephrine program).
The bill also increases the amount of a fine for a manufacturer's
failure to comply with the requirements of the insulin affordability program, the requirements for the emergency supply of prescription insulin, and the epinephrine program to the amount and frequency that is permitted under the Colorado Consumer Protection Act.
The bill requires the state board of pharmacy to provide flyers to
be distributed to pharmacies about the epinephrine program that include a quick response (QR) code to allow individuals to access and complete the epinephrine program's application online. The completed, printed application will include a billing code or other method for the dispensing pharmacy to be reimbursed for the cost of the epinephrine auto-injector above any required cost sharing by the individual.
